BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21041264)

  • 1. Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction?
    Hession MT; Au SC; Gottlieb AB
    J Rheumatol; 2010 Nov; 37(11):2430-2. PubMed ID: 21041264
    [No Abstract]   [Full Text] [Related]  

  • 2. Human Parvovirus B19 and juvenile systemic lupus erythematosus.
    Medrano San Ildefonso MM; Mauri Llerda JA
    Clin Exp Rheumatol; 2004; 22(4):504-5. PubMed ID: 15301256
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of parvovirus B19 infection with systemic lupus erythematosus: role of Th1 predominance.
    Park SJ; Kim JH; Ha TS; Shin JI
    J Rheumatol; 2011 Jun; 38(6):1221. PubMed ID: 21632693
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection.
    Kalt M; Gertner E
    J Rheumatol; 2001 Oct; 28(10):2335-6. PubMed ID: 11669178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus syndrome after parvovirus B19 infection.
    Roblot P; Roblot F; Ramassamy A; Becq-Giraudon B
    Rev Rhum Engl Ed; 1997 Dec; 64(12):849-51. PubMed ID: 9476277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus associated with acute parvovirus B19 infection.
    Díaz F; Collazos J; Mendoza F; De La Viuda JM; Cazallas J; Urkijo JC; Flores M
    Clin Microbiol Infect; 2002 Feb; 8(2):115-7. PubMed ID: 11952726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?
    Aslanidis S; Pyrpasopoulou A; Kontotasios K; Doumas S; Zamboulis C
    Eur J Intern Med; 2008 Jul; 19(5):314-8. PubMed ID: 18549931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular evidence for association of SLE with parvovirus B19.
    Pavlovic M; Kats A; Cavallo M; Shoenfeld Y
    Lupus; 2010 Jun; 19(7):783-92. PubMed ID: 20511275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpartum lupus erythematosus associated with parvovirus B19 infection.
    Nigro G; Piazze J; Taliani G; Mazzocco M; Cassinotti P; Cosmi EV
    J Rheumatol; 1997 May; 24(5):968-70. PubMed ID: 9150091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
    Ohtsuka T; Yamazaki S
    Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19.
    Bengtsson A; Widell A; Elmstâhl S; Sturfelt G
    Ann Rheum Dis; 2000 Jan; 59(1):64-6. PubMed ID: 10627430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic manifestations of Parvovirus B19 infections].
    Sève P; Ferry T; Charhon A; Calvet A; Broussolle C
    Rev Med Interne; 2004 Oct; 25(10):740-51. PubMed ID: 15471600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection.
    Ideguchi H; Ohno S; Ishigatsubo Y
    Rheumatol Int; 2007 Feb; 27(4):411-4. PubMed ID: 17028860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year follow-up study after human parvovirus B19 infection.
    Seishima M; Oyama Z; Yamamura M
    Dermatology; 2003; 206(3):192-6. PubMed ID: 12673074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 and immune disorders.
    Pugliese A; Beltramo T; Torre D; Roccatello D
    Cell Biochem Funct; 2007; 25(6):639-41. PubMed ID: 16917962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic modulation of the autoimmune response following parvovirus B19 infection.
    Vigeant P; Ménard HA; Boire G
    J Rheumatol; 1994 Jun; 21(6):1165-7. PubMed ID: 7932438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the role of parvo virus B19 in arthropathies of Egyptian adult cases.
    Ramadan M; el-Aziz AA; Helmy M; Saleh L; Tamara F
    J Egypt Public Health Assoc; 1998; 73(1-2):31-40. PubMed ID: 17249209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19 infection and antiphospholipid antibodies.
    von Landenberg P; Lehmann HW; Modrow S
    Autoimmun Rev; 2007 Apr; 6(5):278-85. PubMed ID: 17412298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus-like presentation of parvovirus B19 infection.
    Narváez Garcia FJ; Domingo-Domènech E; Castro-Bohorquez FJ; Biosca M; Garcia-Quintana A; Perez-Vega C; Vilaseca-Momplet J
    Am J Med; 2001 Nov; 111(7):573-5. PubMed ID: 11705435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.